| RS2495140482 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2495140844 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2495149011 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2495153923 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495155336 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495160136 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495166674 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS2495167615 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS2495176679 |
PAX6
|
Health Risk |
Likely pathogenic |
Irido-corneo-trabecular dysgenesis, Irido-corneo-trabecular dysgenesis |
| RS2495180066 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS2495181137 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS2495184504 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495187032 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495194878 |
PTPRJ
|
Health Risk |
Pathogenic |
Thrombocytopenia 10, Thrombocytopenia 10 |
| RS2495222321 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495223270 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495225078 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495225308 |
FAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495225676 |
FAS
|
Health Risk |
Likely pathogenic |
— |
| RS2495225911 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495226256 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495227180 |
FAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495228618 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2495230982 |
PACS1
|
Health Risk |
Likely pathogenic |
Schuurs-Hoeijmakers syndrome, Schuurs-Hoeijmakers syndrome |
| RS2495260613 |
TMEM151A
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia 3, Episodic kinesigenic dyskinesia 3 |
| RS2495260968 |
TMEM151A
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia 3, Episodic kinesigenic dyskinesia 3 |
| RS2495261382 |
TMEM151A
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia 3, Episodic kinesigenic dyskinesia 3 |
| RS2495261927 |
TMEM151A
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia 3, Episodic kinesigenic dyskinesia 3 |
| RS2495273817 |
CTSF
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2495276170 |
CTSF
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 13, Neuronal ceroid lipofuscinosis 13 |
| RS2495284476 |
CTSF
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2495286249 |
CTSF
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2495288342 |
PIDD1
|
Health Risk |
Pathogenic |
— |
| RS2495296956 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2495305792 |
KMT5B
|
Health Risk |
Likely pathogenic |
— |
| RS2495306873 |
KMT5B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 51 |
| RS2495317090 |
TOP6BL
|
Health Risk |
Likely pathogenic |
Hydatidiform mole, recurrent |
| RS2495319114 |
ANXA7
|
Health Risk |
Likely pathogenic |
— |
| RS2495319282 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS2495327532 |
COL4A1
|
Health Risk |
Pathogenic |
— |
| RS2495347646 |
KMT5B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 51 |
| RS2495347764 |
KMT5B
|
Health Risk |
Likely pathogenic |
— |
| RS2495348905 |
KMT5B
|
Health Risk |
Likely pathogenic |
— |
| RS2495369149 |
MICU1
|
Health Risk |
Pathogenic |
— |
| RS2495369415 |
MICU1
|
Health Risk |
Pathogenic |
— |
| RS2495370637 |
MICU1
|
Health Risk |
Likely pathogenic |
Proximal myopathy with extrapyramidal signs, Proximal myopathy with extrapyramidal signs |
| RS2495378431 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495380515 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495380745 |
PGAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hyperphosphatasia with intellectual disability syndrome 3 |
| RS2495382261 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495384629 |
B4GAT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 |
| RS2495387711 |
AIP
|
Health Risk |
Pathogenic |
— |
| RS2495388599 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495391310 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495396380 |
AIP
|
Health Risk |
Pathogenic |
— |
| RS2495399241 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495399570 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495400122 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495400851 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495401264 |
AIP
|
Health Risk |
Likely pathogenic |
Somatotroph adenoma, Somatotroph adenoma |
| RS2495401265 |
PC
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495401581 |
AIP
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2495401766 |
AIP
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2495404851 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495404901 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2495405101 |
AIP
|
Health Risk |
Pathogenic |
— |
| RS2495405147 |
AIP
|
Health Risk |
Pathogenic/Likely pathogenic |
Somatotroph adenoma, Somatotroph adenoma |
| RS2495405821 |
AIP
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2495406056 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495406063 |
DPF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2495406855 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495407169 |
DPF2
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 7, Coffin-Siris syndrome 7 |
| RS2495407485 |
AIP
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2495409667 |
AIP
|
Health Risk |
Pathogenic |
— |
| RS2495409867 |
AIP
|
Health Risk |
Likely pathogenic |
Somatotroph adenoma, Somatotroph adenoma |
| RS2495410101 |
AIP
|
Health Risk |
Pathogenic |
— |
| RS2495410373 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495411828 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495413658 |
DPF2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2495413705 |
DPF2
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 7, Coffin-Siris syndrome 7 |
| RS2495413781 |
DPF2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2495414125 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495416125 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495420847 |
SERPING1
|
Health Risk |
Likely pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS2495420852 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS2495420943 |
SERPING1
|
Health Risk |
Pathogenic |
— |
| RS2495421098 |
SERPING1
|
Health Risk |
Likely pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS2495421134 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS2495421197 |
SERPING1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Hereditary angioedema type 1 |
| RS2495421234 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495421429 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495424954 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS2495425144 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS2495425169 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS2495425174 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS2495425264 |
SERPING1
|
Health Risk |
Pathogenic |
Angioedema, Angioedema |
| RS2495425553 |
SERPING1
|
Health Risk |
Pathogenic |
— |
| RS2495425632 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2495425731 |
SERPING1
|
Health Risk |
Pathogenic |
— |
| RS2495426038 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |